Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression-Reference-Cited by-同舟云学术

Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression

Published:2021-06-10 Issue:3 Volume:88 Page:513-524
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Sugiu Kazuhisa,Tazawa Hiroshi^ORCID,Hasei Joe^ORCID,Yamakawa Yasuaki^ORCID,Omori Toshinori,Komatsubara Tadashi,Mochizuki Yusuke^ORCID,Kondo Hiroya^ORCID,Osaki Shuhei^ORCID,Fujiwara Tomohiro^ORCID,Yoshida Aki^ORCID,Kunisada Toshiyuki^ORCID,Ueda Koji^ORCID,Urata Yasuo,Kagawa Shunsuke^ORCID,Ozaki Toshifumi,Fujiwara Toshiyoshi^ORCID

Funder

The Japan Agency for Medical Research and Development

The Ministry of Education, Culture, Sports, Science, and Technology, Japan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-021-04310-5.pdf

Reference45 articles.

1. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics. CA Cancer J Clin 68(1):7–30. https://doi.org/10.3322/caac.21442

2. Lamplot JD, Denduluri S, Qin J, Li R, Liu X, Zhang H, Chen X, Wang N, Pratt A, Shui W, Luo X, Nan G, Deng ZL, Luo J, Haydon RC, He TC, Luu HH (2013) The current and future therapies for human osteosarcoma. Curr Cancer Ther Rev 9(1):55–77. https://doi.org/10.2174/1573394711309010006